267 related articles for article (PubMed ID: 14970859)
1. Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma.
Weichert W; Denkert C; Schmidt M; Gekeler V; Wolf G; Köbel M; Dietel M; Hauptmann S
Br J Cancer; 2004 Feb; 90(4):815-21. PubMed ID: 14970859
[TBL] [Abstract][Full Text] [Related]
2. Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications.
Weichert W; Kristiansen G; Winzer KJ; Schmidt M; Gekeler V; Noske A; Müller BM; Niesporek S; Dietel M; Denkert C
Virchows Arch; 2005 Apr; 446(4):442-50. PubMed ID: 15785925
[TBL] [Abstract][Full Text] [Related]
3. Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades.
Weichert W; Schmidt M; Gekeler V; Denkert C; Stephan C; Jung K; Loening S; Dietel M; Kristiansen G
Prostate; 2004 Aug; 60(3):240-5. PubMed ID: 15176053
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of polo-like kinase 1 in human gastric cancer.
Weichert W; Ullrich A; Schmidt M; Gekeler V; Noske A; Niesporek S; Buckendahl AC; Dietel M; Denkert C
Cancer Sci; 2006 Apr; 97(4):271-6. PubMed ID: 16630118
[TBL] [Abstract][Full Text] [Related]
5. Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma.
Kanaji S; Saito H; Tsujitani S; Matsumoto S; Tatebe S; Kondo A; Ozaki M; Ito H; Ikeguchi M
Oncology; 2006; 70(2):126-33. PubMed ID: 16645325
[TBL] [Abstract][Full Text] [Related]
6. Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.
Yang GF; Xie D; Liu JH; Luo JH; Li LJ; Hua WF; Wu HM; Kung HF; Zeng YX; Guan XY
Gynecol Oncol; 2009 Feb; 112(2):314-8. PubMed ID: 19054548
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells.
Spänkuch-Schmitt B; Wolf G; Solbach C; Loibl S; Knecht R; Stegmüller M; von Minckwitz G; Kaufmann M; Strebhardt K
Oncogene; 2002 May; 21(20):3162-71. PubMed ID: 12082631
[TBL] [Abstract][Full Text] [Related]
8. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
[TBL] [Abstract][Full Text] [Related]
9. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer.
Reagan-Shaw S; Ahmad N
FASEB J; 2005 Apr; 19(6):611-3. PubMed ID: 15661849
[TBL] [Abstract][Full Text] [Related]
10. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues.
Winkles JA; Alberts GF
Oncogene; 2005 Jan; 24(2):260-6. PubMed ID: 15640841
[TBL] [Abstract][Full Text] [Related]
12. [Polo like kinase 1 expression and prognostic value in gastric carcinomas].
Lan B; Liu BY; Chen XH; Qu Y; Zhang XQ; Cai Q; Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):70-2. PubMed ID: 17253180
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancer.
Wang ZX; Xue D; Liu ZL; Lu BB; Bian HB; Pan X; Yin YM
Int J Biochem Cell Biol; 2012 Jan; 44(1):200-10. PubMed ID: 22064247
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis.
Weichert W; Gekeler V; Denkert C; Dietel M; Hauptmann S
Int J Oncol; 2003 Sep; 23(3):633-9. PubMed ID: 12888898
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Polo-like kinase 1 is a common and early event in pancreatic cancer.
Weichert W; Schmidt M; Jacob J; Gekeler V; Langrehr J; Neuhaus P; Bahra M; Denkert C; Dietel M; Kristiansen G
Pancreatology; 2005; 5(2-3):259-65. PubMed ID: 15855824
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of Polo-like kinase 1 (PLK1) expression in human malignant glioma.
Cheng MW; Wang BC; Weng ZQ; Zhu XW
Acta Histochem; 2012 Sep; 114(5):503-9. PubMed ID: 22000864
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic effect of Polo-like kinase 1 expression in human gastric carcinomas.
Jang YJ; Kim YS; Kim WH
Int J Oncol; 2006 Sep; 29(3):589-94. PubMed ID: 16865274
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival.
Zhao F; Siu MK; Jiang L; Tam KF; Ngan HY; Le XF; Wong OG; Wong ES; Chan HY; Cheung AN
Histopathology; 2011 Dec; 59(6):1163-72. PubMed ID: 22175896
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma.
Denkert C; Köbel M; Pest S; Koch I; Berger S; Schwabe M; Siegert A; Reles A; Klosterhalfen B; Hauptmann S
Am J Pathol; 2002 Mar; 160(3):893-903. PubMed ID: 11891188
[TBL] [Abstract][Full Text] [Related]
20. Polo-like kinases (Plks) and cancer.
Takai N; Hamanaka R; Yoshimatsu J; Miyakawa I
Oncogene; 2005 Jan; 24(2):287-91. PubMed ID: 15640844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]